Articles with "patients luad" as a keyword



Serum sPD1 and sPDL1 as Biomarkers for Evaluating the Immune State of Lung Adenocarcinoma Patients

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Immunology Research"

DOI: 10.1155/2022/9101912

Abstract: A large proportion of cancer patients benefit from immune checkpoint therapy, while few studies focused on the relationship between soluble PD1 (sPD1) and soluble PDL1 (sPDL1) in serum and immune status of patients. ILC2 and… read more here.

Keywords: patients luad; spdl1; spd1 spdl1; serum spd1 ... See more keywords
Photo by ospanali from unsplash

SNX20 Expression Correlates with Immune Cell Infiltration and Can Predict Prognosis in Lung Adenocarcinoma

Sign Up to like & get
recommendations!
Published in 2021 at "International Journal of General Medicine"

DOI: 10.2147/ijgm.s337198

Abstract: Background Sorting nexin-20 (SNX20) is a member of the sorting nexin family of proteins. It plays a crucial role in the regulation of innate immunity. However, the prognostic risk, potential mechanisms, immunotherapy, and other functions… read more here.

Keywords: expression; snx20; prognosis; snx20 expression ... See more keywords
Photo by sharonmccutcheon from unsplash

Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Endocrinology"

DOI: 10.3389/fendo.2022.829175

Abstract: Background Lung cancer has been a prominent research focus in recent years due to its role in cancer-related fatalities globally, with lung adenocarcinoma (LUAD) being the most prevalent histological form. Nonetheless, no signature of lactate… read more here.

Keywords: patients luad; lactate metabolism; lung adenocarcinoma; signature ... See more keywords
Photo by sharonmccutcheon from unsplash

Development and validation of a TRP-related gene signature for overall survival prediction in lung adenocarcinoma

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Genetics"

DOI: 10.3389/fgene.2022.905650

Abstract: The transient receptor potential (TRP) channel is a type of channel protein widely distributed in peripheral and central nervous systems. Genes encoding TRP can be regulated by natural aromatic substances and serve as a therapeutic… read more here.

Keywords: trp related; patients luad; lung adenocarcinoma; overall survival ... See more keywords
Photo by sharonmccutcheon from unsplash

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma

Sign Up to like & get
recommendations!
Published in 2023 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2023.1127768

Abstract: Background Cuproptosis is a novel form of programmed cell death that disrupts the tricarboxylic acid (TCA) cycle and mitochondrial function. The mechanism of cuproptosis is quite different from that of common forms of cell death… read more here.

Keywords: cuproptosis; patients luad; lung adenocarcinoma; immunotherapy ... See more keywords
Photo by sharonmccutcheon from unsplash

Cyclin B1 expression as an independent prognostic factor for lung adenocarcinoma and its potential pathways

Sign Up to like & get
recommendations!
Published in 2022 at "Oncology Letters"

DOI: 10.3892/ol.2022.13561

Abstract: Although great progress has been made in the early diagnosis and targeted therapy of lung adenocarcinoma (LUAD), the survival of patients with LUAD remains unsatisfactory. There is an urgent requirement for new biomarkers to guide… read more here.

Keywords: ccnb1; patients luad; lung adenocarcinoma; expression ... See more keywords